Patent US4330557A successfully refreshed from Google Patents.
US4330557A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Acyl-carnitine and use thereof in parenteral administration of triglycerides
Assignee: Individual
•
Filing: 1980-03-17
•
Granted: 1982-05-18
•
Expires: 2000-03-17
Abstract
Abstract A composition for total or supplemental parenteral nutrition of patients in need thereof for the treatment of shock and trauma is disclosed. The composition comprises a therapeutically effective amount of triglycerides and an amount of an acyl-carnitine, typically acetyl-carnitine, or a pharmaceutically acceptable salt thereof sufficient to increase free fatty acid oxidation.
Inventors
- 👤 Claudio Cavazza
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 18:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/22
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
97 words
In the method of increasing in a human the level of fatty acids selected from the group consisting of oleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid by parenteral intravenous administration of one or more triglycerides of said fatty acid to a human, the improvement which comprises sumultaneously administering a quantity of an acyl-carnitine sufficient to enhance the oxidation of said fatty acids in the body of said human, said acyl-carnitine having the general formula ##STR3## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotonyl.
Claim 2
Dependent Claim
97 words
In the method of increasing in a human the level of fatty acids selected from the group consisting of oleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid by parenteral intravenous administration of one or more triglycerides of said fatty acid to a human, the improvement which comprises sumultaneously administering a quantity of an acyl-carnitine sufficient to enhance the oxidation of said fatty acids in the body of said human, said acyl-carnitine having the general formula ##STR3## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotonyl.
Claim 3
Independent Claim
78 words
A method of treating patients in need of total parenteral nutrition, which comprises parenterally administering to a patient in need thereof an amount of physiologically acceptable triglycerides therapeutically effective for nourishing said patient and in combination therewith an amount of an acyl-carnitine of the general formula: ##STR4## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotonyl or a pharmaceutically acceptable salt thereof sufficient to increase free fatty acid oxidation.
Claim 4
Independent Claim
78 words
A method of treating patients in need of total parenteral nutrition, which comprises parenterally administering to a patient in need thereof an amount of physiologically acceptable triglycerides therapeutically effective for nourishing said patient and in combination therewith an amount of an acyl-carnitine of the general formula: ##STR4## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotonyl or a pharmaceutically acceptable salt thereof sufficient to increase free fatty acid oxidation.
Claim 5
Dependent Claim
12 words
The method according to claim 1, wherein said acyl-carnitine is an L-acyl-carnitine.
Claim 6
Dependent Claim
41 words
The method according to claim 1, which further comprises orally or parenterally administering daily for 12 to 24 hours after discontinuation of said triglyceride administration, from about 30 mg to about 200 mg of said acyl-carnitine per kg of body weight.
Claim 7
Dependent Claim
118 words
A parenterally administerable aqueous intravenous pharmaceutical composition for increasing in the body of a human recipient thereof the level of fatty acids selected from the group consisting of oleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid, said composition comprising a quantity of one or more triglycerides of said fatty acids sufficient upon hydrolysis in the body to afford a nutritionally effective amount of said fatty acid, and an amount of an acyl-carnitine or a pharmaceutically acceptable salt thereof sufficient to enhance the oxidation of said fatty acids in the body, said acyl-carnitine having the general formula ##STR5## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotony.
Claim 8
Dependent Claim
118 words
A parenterally administerable aqueous intravenous pharmaceutical composition for increasing in the body of a human recipient thereof the level of fatty acids selected from the group consisting of oleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid, said composition comprising a quantity of one or more triglycerides of said fatty acids sufficient upon hydrolysis in the body to afford a nutritionally effective amount of said fatty acid, and an amount of an acyl-carnitine or a pharmaceutically acceptable salt thereof sufficient to enhance the oxidation of said fatty acids in the body, said acyl-carnitine having the general formula ##STR5## wherein R represents acetyl, propionyl, butyryl, hydroxy butyryl, hexanoyl, octanoyl, decanoyl, palmitoyl, stearoyl, acetoacetyl, succinyl, isovaleryl and crotony.
Claim 9
Dependent Claim
24 words
The composition according to claim 5, wherein said amount of acyl-carnitine or pharmaceutically acceptable salt thereof is from about 2 to about 30 g/l.
Claim 10
Dependent Claim
47 words
The composition according to claim 5 comprising: ______________________________________
soybean oil 50-200 g/l
glycerine 22-26 g/l
egg yolk phospolipids (ovolecithin)
10.5-12.5 g/l
acetyl-carnitine or a pharmaceutically
acceptable salt thereof
5-25 g/l
sodium hydroxide sufficient to adjust
pH of composition
to 5.5-9.0
distilled water balance to 1 liter.
______________________________________
Claim 11
Dependent Claim
37 words
The composition according to claim 5, comprising: ______________________________________
cottonseed oil 100-200 g/l
soybean lecithin 10-30 g/l
sorbitol 40-60 g/l
D,L-α-tocopherol
0.5-1 g/l
acetyl-carnitine or pharmaceutically
acceptable salt thereof
5-25 g/l
distilled water balance to 1 liter.
______________________________________
Claim 12
Dependent Claim
34 words
The composition according to claim 5, comprising ______________________________________
sesame oil 100-200 g/l
glycerine 20-30 g/l
cetylstearylsulfonic acid
1-1.5 g/l
propionyl-carnitine or pharmaceutically
acceptable salt thereof
3-20 g/l
distilled water balance to 1 liter
______________________________________
Claim 13
Dependent Claim
36 words
The composition according to claim 5, comprising: ______________________________________
safflower oil 100-200 g/l
sorbitol 50-70 g/l
polysorbate 8-12 g/l
D,L-α-tocopherol
0.5-1 g/l
acetoacetyl-carnitine or
pharmaceutically acceptable
salt thereof 2-20 g/l
distilled water balance to 1 liter
______________________________________
Claim 14
Dependent Claim
11 words
The composition according to claim 5, wherein said acyl-carnitine is L-acyl-carnitine.
Claim 15
Dependent Claim
11 words
The composition according to claim 7, wherein said acetyl-carnitine is L-acetyl-carnitine.
Claim 16
Dependent Claim
11 words
The composition according to claim 8, wherein said acetyl-carnitine is L-acetyl-carnitine.
Claim 17
Dependent Claim
11 words
The composition according to claim 2, wherein said propionyl-carnitine is L-propionyl-carnitine.
References Cited (Backward Citations)
US3793450A
Cited
US3810994A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-05-17 | 1985-11-16 | 1986-05-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-05-17 | 1989-11-16 | 1990-05-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-05-17 | 1993-11-16 | 1994-05-18 | $7700.00 | Window Closed / Lapsed |